ArticleJAMA network open2022

Evaluation of Representation of Women as Authors in Pivotal Trials Supporting US Food and Drug Administration Approval of Novel Cardiovascular Drugs.

Izza Shahid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.